By Marco Piccolo Key highlights: Windtree Therapeutics has been delisted from Nasdaq after failing to maintain the $1 minimum bid price. The company recently pivoted from biotech to a digital asset treasury strategy focused on Binance’s BNB token. Shares collapsed more than 90% in a month, forcing Windtree to move to over-the-counter (OTC) trading. Windtree […]